Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance—Letter
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-0164
Full Text
Open PDFAbstract
Available in full text
Date
May 15, 2019
Authors
Publisher
American Association for Cancer Research (AACR)